Avoro Capital Advisors LLC Aadi Bioscience, Inc. Transaction History
Avoro Capital Advisors LLC
- $6.86 Billion
- Q4 2024
A detailed history of Avoro Capital Advisors LLC transactions in Aadi Bioscience, Inc. stock. As of the latest transaction made, Avoro Capital Advisors LLC holds 2,849,402 shares of AADI stock, worth $6.3 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
2,849,402
Previous 2,849,402
-0.0%
Holding current value
$6.3 Million
Previous $5.87 Million
53.42%
% of portfolio
0.13%
Previous 0.09%
Shares
2 transactions
Others Institutions Holding AADI
# of Institutions
57Shares Held
15.6MCall Options Held
15KPut Options Held
3.1K-
Qvt Financial LP New York, NY2.31MShares$5.11 Million0.72% of portfolio
-
Bml Capital Management, LLC Zionsville, IN2.1MShares$4.64 Million4.12% of portfolio
-
Acuta Capital Partners, LLC Belmont, CA1.85MShares$4.09 Million8.31% of portfolio
-
Acorn Capital Advisors, LLC New York, NY1.15MShares$2.53 Million1.96% of portfolio
-
Ally Bridge Group (Ny) LLC New York, NY818KShares$1.81 Million2.93% of portfolio
About Aadi Bioscience, Inc.
- Ticker AADI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 21,016,800
- Market Cap $46.4M
- Description
- Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, ...